B&J Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.84 Cr
as on 15-11-2024
- Revenue 81.75%
(FY 2023)
- Profit -28.23%
(FY 2023)
- Ebitda 27.25%
(FY 2023)
- Net Worth 100.18%
(FY 2023)
- Total Assets 29.69%
(FY 2023)
About B&J Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.84 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pandian Sundararajan and Sundararajan Raghavan serve as directors at the Company.
- CIN/LLPIN
U51909TN2018PTC124472
- Company No.
124472
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at B&J Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pandian Sundararajan  | Director | 10-Sep-2018 | Current |
| Sundararajan Raghavan | Director | 10-Sep-2018 | Current |
Financial Performance of B&J Healthcare.
B&J Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 81.75% increase. The company also saw a substantial fall in profitability, with a 28.23% decrease in profit. The company's net worth Soared by an impressive increase of 100.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B&J Healthcare?
Unlock access to B&J Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Avana Surgical Systems Private LimitedActive 6 years 9 monthsPandian Sundararajan is a mutual person
Avana Medical Devices Private LimitedActive 15 years 7 monthsPandian Sundararajan is a mutual person
Avana Technology Services Private LimitedActive 6 months 11 daysPandian Sundararajan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 09 Nov 2021 | ₹3.40 M | Satisfied |
Canara Bank Creation Date: 13 Mar 2019 | ₹1.50 Cr | Satisfied |
How Many Employees Work at B&J Healthcare?
B&J Healthcare has a workforce of 21 employees as of Oct 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B&J Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B&J Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
